A U.S. trade regulator on Friday announced a suite of actions taking aim at "unfair and deceptive practices" it said are ...
After a yearlong inquiry, the Federal Trade Commission warned brands not to gag their small business operators or charge them ...
Commonwealth Fusion Systems (CFS) is shipping a pair of its specialized magnets to the University of Wisconsin-Madison, the ...
The FTC opened an investigation in June 2022 into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime ...
The FTC’s interim report, titled “Pharmacy Benefit Managers: Ten Powerful Middlemen Inflating Drug Costs and Squeezing Main ...
Federal regulators plan to sue the top three pharmacy-benefit managers over how they negotiate prices for drugs, including ...
PBMs and brand drug manufacturers sometimes negotiate drug rebates that limit access to lower-cost generic alternatives, FTC ...
According to the FTC, this power allows pharmacy benefit managers (PBMs) to “significantly influence what drugs are available ...
The news comes just one day after the FTC announced it had completed a two-year investigation into the industry. Pharmacy ...
What that memo described, according to a new report from the Federal Trade Commission, is standard operating procedure among ...
Pharmacy benefit managers (PBMs) wield enormous power on the accessibility and affordability of prescription drugs, and a ...
The Federal Trade Commission on Tuesday ... agency’s yearslong inquiry into the drug middlemen, which remains ongoing,and comes after a bipartisan group of senators urged the agency to release a ...